Abstract
Efficacy and Safety of Low- and High-Dose Perampanel as First Adjunctive Therapy in Patients With Partial-Onset Seizures (POS) With or Without Secondarily Generalized Seizures (SGS): Post Hoc Analysis of the FAME Study (1382)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have